Advances in Diagnostics and Prognostics in the Management of Intrathoracic Malignancies

Dear Colleagues,

Within the dynamic landscape of oncology, the management of intrathoracic malignancies has always been at the forefront of medical and technological advances with respect to diagnostic and prognostic innovations. As we have delved deeper into the intricacies of this disease's biology, our understanding of its aggressiveness, patterns, and symptomatology has expanded. Consequently, there is a pressing need to further enhance our diagnostic methods, enabling the earlier detection and monitoring of minimal-residual disease and micro-metastatic disease. Traditional staging systems, while valuable, may fall short in elucidating the complexities of disease patterns in the current era. Thus, the integration of molecular biomarkers, radiomics, artificial intelligence, and immunobiological parameters is imperative to provide comprehensive insights into disease prognosis.

This Special Issue will delve into the pivotal strides made in diagnostics and prognostics for intrathoracic malignancies, illuminating contemporary approaches shaping clinical practice. By harnessing cutting-edge technologies and insights, this collection seeks to showcase real-world examples, providing clinicians with essential tools to navigate complexities, optimize patient care, and advance towards more precise, personalized therapeutic strategies in the fight against intrathoracic cancers.

Dr. Akshay Jatin Patel
Dr. Marcus Taylor
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• intrathoracic malignancies
• diagnostics
• prognostics
• molecular biomarkers
• radiomics
• artificial intelligence
• immunobiological parameters
• personalized therapy